MediBuddy, a popular digital healthcare platform in India, recently received an additional $18 million in funding from its existing investors, including Quadria Capital, Lightrock, and TEAMFund. This extra money will help the company grow and expand by making strategic acquisitions.
Back in February 2022, MediBuddy raised an impressive $125 million during its Series C funding round. With this new funding, they are in a strong position to achieve their ambitious growth goals over the next three years. They plan to use a significant portion of this money to buy other companies that can help them grow and to improve their existing services.
Satish Kannan, the Co-Founder and CEO of MediBuddy, said that their partnership with investors has been crucial for their growth and their mission to provide quality healthcare to a billion people in India. The company has been growing rapidly, with a Compound Annual Growth Rate (CAGR) of 95.5% over the past three years. This new funding will be important for their acquisition plans and expanding their services.
MediBuddy has been successful in both the corporate and retail healthcare sectors. They have recently acquired companies like Clinix, which focuses on medical consultations in rural India, and the Indian branch
of Aetna Inc.’s vHealth, which has strengthened their presence in the healthcare industry.As MediBuddy aims for long-term profitability, this new funding shows that they are a leader in the health-tech industry. They help over 35,000 users every day by offering easy access to specialist doctors 24/7, 365 days a year. Their convenience and fast service have made online doctor consultations more popular, and they already have over 30 million Indian users. Their ability to secure substantial funding and grow steadily demonstrates their vision and operational excellence.
MediBuddy funding and growth in India, MediBuddy funding and growth in India, Looking for latest chemistry and Pharma job openings, follow Rasayanika Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma job.
